[Laboratory and clinical evaluation of clindamycin].
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D004697:Endocarditis, Bacterial / Q000188:drug therapy; D004751:Enteritis / Q000188:drug therapy; D004755:Enterobacteriaceae / Q000187:drug effects; D005260:Female; D006027:Glycosides / Q000494:pharmacology / Q000627:therapeutic use; D006726:Hordeolum / Q000188:drug therapy; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010033:Otitis Media / Q000188:drug therapy; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D011759:Pyrrolidines / Q000494:pharmacology / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D006027:Glycosides; D011759:Pyrrolidines